{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T14:29:43Z","timestamp":1790260183103,"version":"4.1.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,5,16]],"date-time":"2016-05-16T00:00:00Z","timestamp":1463356800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2016,5,16]],"date-time":"2016-05-16T00:00:00Z","timestamp":1463356800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["U01NS069997"],"award-info":[{"award-number":["U01NS069997"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12967-016-0895-8","type":"journal-article","created":{"date-parts":[[2016,5,16]],"date-time":"2016-05-16T11:20:00Z","timestamp":1463397600000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Single dose GLP toxicity and biodistribution study of a conditionally replicative adenovirus vector, CRAd-S-pk7, administered by intracerebral injection to Syrian hamsters"],"prefix":"10.1186","volume":"14","author":[{"given":"Julius Woongki","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda","family":"Auffinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Drew A.","family":"Spencer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Miska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan L.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua Robert","family":"Kane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob S.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak","family":"Kanojia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill F.","family":"Mann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingjiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meijing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atique U.","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen S.","family":"Aboody","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa V.","family":"Strong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles D.","family":"H\u00e9bert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maciej S.","family":"Lesniak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,5,16]]},"reference":[{"issue":"Suppl 2","key":"895_CR1","doi-asserted-by":"publisher","first-page":"ii24","DOI":"10.1093\/neuonc\/nou355","volume":"17","author":"JR Kane","year":"2015","unstructured":"Kane JR, Miska J, Young JS, Kanojia D, Kim JW, Lesniak MS. Sui generis: gene therapy and delivery systems for the treatment of glioblastoma. Neuro Oncol. 2015;17(Suppl 2):ii24\u201336. doi:\n                    10.1093\/neuonc\/nou355\n                    \n                  .","journal-title":"Neuro Oncol"},{"key":"895_CR2","doi-asserted-by":"publisher","DOI":"10.1089\/hum.2015.008","author":"JW Kim","year":"2015","unstructured":"Kim JW, Kane JR, Young JS, Chang A, Kanojia D, Morshed R, et al. A genetically modified adenoviral vector with a phage display derived peptide incorporated into fiber fibritin chimera prolongs survival in experimental glioma. Hum Gene Ther. 2015. doi:\n                    10.1089\/hum.2015.008\n                    \n                  .","journal-title":"Hum Gene Ther"},{"issue":"6","key":"895_CR3","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1517\/14712590902988451","volume":"9","author":"S Nandi","year":"2009","unstructured":"Nandi S, Lesniak MS. Adenoviral virotherapy for malignant brain tumors. Expert Opin Biol Ther. 2009;9(6):737\u201347. doi:\n                    10.1517\/14712590902988451\n                    \n                  .","journal-title":"Expert Opin Biol Ther"},{"issue":"3","key":"895_CR4","first-page":"729","volume":"34","author":"IV Ulasov","year":"2009","unstructured":"Ulasov IV, Tyler MA, Zhu ZB, Han Y, He TC, Lesniak MS. Oncolytic adenoviral vectors which employ the survivin promoter induce glioma oncolysis via a process of beclin-dependent autophagy. Int J Oncol. 2009;34(3):729\u201342.","journal-title":"Int J Oncol"},{"issue":"7","key":"895_CR5","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1089\/hum.2007.002","volume":"18","author":"IV Ulasov","year":"2007","unstructured":"Ulasov IV, Zhu ZB, Tyler MA, Han Y, Rivera AA, Khramtsov A, et al. Survivin-driven and fiber-modified oncolytic adenovirus exhibits potent antitumor activity in established intracranial glioma. Hum Gene Ther. 2007;18(7):589\u2013602. doi:\n                    10.1089\/hum.2007.002\n                    \n                  .","journal-title":"Hum Gene Ther"},{"issue":"4","key":"895_CR6","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1172\/JCI5309","volume":"103","author":"C Hidaka","year":"1999","unstructured":"Hidaka C, Milano E, Leopold PL, Bergelson JM, Hackett NR, Finberg RW, et al. CAR-dependent and CAR-independent pathways of adenovirus vector-mediated gene transfer and expression in human fibroblasts. J Clin Investig. 1999;103(4):579\u201387. doi:\n                    10.1172\/jci5309\n                    \n                  .","journal-title":"J Clin Investig"},{"issue":"3","key":"895_CR7","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1002\/jgm.1008","volume":"9","author":"S Zheng","year":"2007","unstructured":"Zheng S, Ulasov IV, Han Y, Tyler MA, Zhu ZB, Lesniak MS. Fiber-knob modifications enhance adenoviral tropism and gene transfer in malignant glioma. J Gene Med. 2007;9(3):151\u201360. doi:\n                    10.1002\/jgm.1008\n                    \n                  .","journal-title":"J Gene Med"},{"issue":"9","key":"895_CR8","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1038\/mt.2011.100","volume":"19","author":"AU Ahmed","year":"2011","unstructured":"Ahmed AU, Thaci B, Alexiades NG, Han Y, Qian S, Liu F, et al. Neural stem cell-based cell carriers enhance therapeutic efficacy of an oncolytic adenovirus in an orthotopic mouse model of human glioblastoma. Mol Ther. 2011;19(9):1714\u201326. doi:\n                    10.1038\/mt.2011.100\n                    \n                  .","journal-title":"Mol Ther"},{"issue":"13","key":"895_CR9","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1093\/jnci\/djt141","volume":"105","author":"AU Ahmed","year":"2013","unstructured":"Ahmed AU, Thaci B, Tobias AL, Auffinger B, Zhang L, Cheng Y, et al. A preclinical evaluation of neural stem cell-based cell carrier for targeted antiglioma oncolytic virotherapy. J Natl Cancer Inst. 2013;105(13):968\u201377. doi:\n                    10.1093\/jnci\/djt141\n                    \n                  .","journal-title":"J Natl Cancer Inst"},{"issue":"13.1","key":"895_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/0471142905.hg1311s85","volume":"85","author":"JW Kim","year":"2015","unstructured":"Kim JW, Kane JR, Young JS, Chang AL, Kanojia D, Qian S, et al. Neural stem cell-mediated delivery of oncolytic adenovirus. Curr Protoc Hum Genet. 2015;85(13.1):1\u20139. doi:\n                    10.1002\/0471142905.hg1311s85\n                    \n                  .","journal-title":"Curr Protoc Hum Genet."},{"issue":"4","key":"895_CR11","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/cgt.2008.80","volume":"16","author":"AM Sonabend","year":"2009","unstructured":"Sonabend AM, Ulasov IV, Han Y, Rolle CE, Nandi S, Cao D, et al. Biodistribution of an oncolytic adenovirus after intracranial injection in permissive animals: a comparative study of Syrian hamsters and cotton rats. Cancer Gene Ther. 2009;16(4):362\u201372. doi:\n                    10.1038\/cgt.2008.80\n                    \n                  .","journal-title":"Cancer Gene Ther"},{"issue":"9","key":"895_CR12","doi-asserted-by":"publisher","first-page":"655","DOI":"10.5966\/sctm.2013-0039","volume":"2","author":"AL Tobias","year":"2013","unstructured":"Tobias AL, Thaci B, Auffinger B, Rincon E, Balyasnikova IV, Kim CK, et al. The timing of neural stem cell-based virotherapy is critical for optimal therapeutic efficacy when applied with radiation and chemotherapy for the treatment of glioblastoma. Stem Cells Transl Med. 2013;2(9):655\u201366. doi:\n                    10.5966\/sctm.2013-0039\n                    \n                  .","journal-title":"Stem Cells Transl Med"},{"issue":"1","key":"895_CR13","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1128\/JVI.02184-14","volume":"89","author":"CM Crosby","year":"2015","unstructured":"Crosby CM, Nehete P, Sastry KJ, Barry MA. Amplified and persistent immune responses generated by single-cycle replicating adenovirus vaccines. J Virol. 2015;89(1):669\u201375. doi:\n                    10.1128\/jvi.02184-14\n                    \n                  .","journal-title":"J Virol"},{"issue":"6","key":"895_CR14","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/cgt.2014.22","volume":"21","author":"S Vijayalingam","year":"2014","unstructured":"Vijayalingam S, Kuppuswamy M, Subramanian T, Strebeck FF, West CL, Varvares M, et al. Evaluation of apoptogenic adenovirus type 5 oncolytic vectors in a Syrian hamster head and neck cancer model. Cancer Gene Ther. 2014;21(6):228\u201337. doi:\n                    10.1038\/cgt.2014.22\n                    \n                  .","journal-title":"Cancer Gene Ther"},{"issue":"9","key":"895_CR15","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.3390\/v2091844","volume":"2","author":"K Toth","year":"2010","unstructured":"Toth K, Wold WS. Increasing the efficacy of oncolytic adenovirus vectors. Viruses. 2010;2(9):1844\u201366. doi:\n                    10.3390\/v2091844\n                    \n                  .","journal-title":"Viruses"},{"issue":"2","key":"895_CR16","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.bbcan.2008.02.001","volume":"1785","author":"ZS Guo","year":"2008","unstructured":"Guo ZS, Thorne SH, Bartlett DL. Oncolytic virotherapy: molecular targets in tumor-selective replication and carrier cell-mediated delivery of oncolytic viruses. Biochim Biophys Acta. 2008;1785(2):217\u201331. doi:\n                    10.1016\/j.bbcan.2008.02.001\n                    \n                  .","journal-title":"Biochim Biophys Acta"},{"issue":"14","key":"895_CR17","doi-asserted-by":"publisher","first-page":"5778","DOI":"10.1158\/0008-5472.CAN-07-6441","volume":"68","author":"S Nandi","year":"2008","unstructured":"Nandi S, Ulasov IV, Tyler MA, Sugihara AQ, Molinero L, Han Y, et al. Low-dose radiation enhances survivin-mediated virotherapy against malignant glioma stem cells. Cancer Res. 2008;68(14):5778\u201384. doi:\n                    10.1158\/0008-5472.CAN-07-6441\n                    \n                  .","journal-title":"Cancer Res"},{"issue":"9","key":"895_CR18","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1002\/jmv.21264","volume":"80","author":"IV Ulasov","year":"2008","unstructured":"Ulasov IV, Tyler MA, Rivera AA, Nettlebeck DM, Douglas JT, Lesniak MS. Evaluation of E1A double mutant oncolytic adenovectors in anti-glioma gene therapy. J Med Virol. 2008;80(9):1595\u2013603. doi:\n                    10.1002\/jmv.21264\n                    \n                  .","journal-title":"J Med Virol"},{"issue":"7","key":"895_CR19","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1038\/sj.bjc.6604969","volume":"100","author":"IV Ulasov","year":"2009","unstructured":"Ulasov IV, Sonabend AM, Nandi S, Khramtsov A, Han Y, Lesniak MS. Combination of adenoviral virotherapy and temozolomide chemotherapy eradicates malignant glioma through autophagic and apoptotic cell death in vivo. Br J Cancer. 2009;100(7):1154\u201364. doi:\n                    10.1038\/sj.bjc.6604969\n                    \n                  .","journal-title":"Br J Cancer"},{"issue":"7","key":"895_CR20","doi-asserted-by":"publisher","first-page":"675","DOI":"10.2217\/fvl.13.47","volume":"8","author":"M Dey","year":"2013","unstructured":"Dey M, Auffinger B, Lesniak MS, Ahmed AU. Antiglioma oncolytic virotherapy: unattainable goal or a success story in the making? Future Virol. 2013;8(7):675\u201393. doi:\n                    10.2217\/fvl.13.47\n                    \n                  .","journal-title":"Future Virol"},{"key":"895_CR21","doi-asserted-by":"publisher","first-page":"32","DOI":"10.3389\/fonc.2013.00032","volume":"3","author":"B Auffinger","year":"2013","unstructured":"Auffinger B, Ahmed AU, Lesniak MS. Oncolytic virotherapy for malignant glioma: translating laboratory insights into clinical practice. Front Oncol. 2013;3:32. doi:\n                    10.3389\/fonc.2013.00032\n                    \n                  .","journal-title":"Front Oncol"},{"issue":"1","key":"895_CR22","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/1476-4598-12-103","volume":"12","author":"DL Bartlett","year":"2013","unstructured":"Bartlett DL, Liu Z, Sathaiah M, Ravindranathan R, Guo Z, He Y, et al. Oncolytic viruses as therapeutic cancer vaccines. Mol Cancer. 2013;12(1):103. doi:\n                    10.1186\/1476-4598-12-103\n                    \n                  .","journal-title":"Mol Cancer"},{"issue":"1","key":"895_CR23","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/cdd.2013.84","volume":"21","author":"H Inoue","year":"2014","unstructured":"Inoue H, Tani K. Multimodal immunogenic cancer cell death as a consequence of anticancer cytotoxic treatments. Cell Death Differ. 2014;21(1):39\u201349. doi:\n                    10.1038\/cdd.2013.84\n                    \n                  .","journal-title":"Cell Death Differ"},{"issue":"4","key":"895_CR24","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1158\/2326-6066.CIR-14-0015","volume":"2","author":"EA Chiocca","year":"2014","unstructured":"Chiocca EA, Rabkin SD. Oncolytic viruses and their application to cancer immunotherapy. Cancer Immunol Res. 2014;2(4):295\u2013300. doi:\n                    10.1158\/2326-6066.CIR-14-0015\n                    \n                  .","journal-title":"Cancer Immunol Res"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-016-0895-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12967-016-0895-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-016-0895-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-016-0895-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T09:48:41Z","timestamp":1589536121000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-016-0895-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,16]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["895"],"URL":"https:\/\/doi.org\/10.1186\/s12967-016-0895-8","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,16]]},"assertion":[{"value":"22 March 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"134"}}